bioAffinity Technologies, Inc. Other Income and Expense
bioAffinity Technologies, Inc. (BIAF) reported Other Income and Expense of -$31.22 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2026-08-07
- bioAffinity Technologies, Inc. nonoperating income (expense) for the quarter ending 2026-06-30 was -$31.22K.
- bioAffinity Technologies, Inc. nonoperating income (expense) for the quarter ending 2026-03-31 was -$13.63K.
- bioAffinity Technologies, Inc. nonoperating income (expense) for the quarter ending 2025-12-31 was $2.68K.
- bioAffinity Technologies, Inc. nonoperating income (expense) for the quarter ending 2025-09-30 was -$2.76M.
- bioAffinity Technologies, Inc. nonoperating income (expense) for fiscal 2025 was -$4.29M.
- bioAffinity Technologies, Inc. nonoperating income (expense) for fiscal 2024 was -$74.74K, a 230.63% decline from fiscal 2023.
- bioAffinity Technologies, Inc. nonoperating income (expense) for fiscal 2023 was $57.21K.
- bioAffinity Technologies, Inc. nonoperating income (expense) for fiscal 2022 was -$4.14M.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$31.22K 10-Q · filed 2026-08-07 | -$44.85K 10-Q · filed 2026-08-07 | -$42.17K derived: sum of 3 quarters · filed 2026-08-07 | -$2.80M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$13.63K 10-Q · filed 2026-05-11 | -$10.96K derived: sum of 2 quarters · filed 2026-05-11 | -$2.77M derived: sum of 3 quarters · filed 2026-05-11 | -$4.28M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $2.68K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$2.75M derived: sum of 2 quarters · filed 2026-03-16 | -$4.27M derived: sum of 3 quarters · filed 2026-08-07 | -$4.29M 10-K · filed 2026-03-16 |
| 2025-09-30 | -$2.76M 10-Q · filed 2025-11-14 | -$4.27M derived: sum of 2 quarters · filed 2026-08-07 | -$4.30M 10-Q · filed 2025-11-14 | -$4.32M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$1.52M 10-Q · filed 2026-08-07 | -$1.54M 10-Q · filed 2026-08-07 | -$1.56M derived: sum of 3 quarters · filed 2026-08-07 | -$1.59M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$24.58K 10-Q · filed 2026-05-11 | -$44.93K derived: sum of 2 quarters · filed 2026-05-11 | -$69.34K derived: sum of 3 quarters · filed 2026-05-11 | -$86.41K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$20.34K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$44.76K derived: sum of 2 quarters · filed 2026-03-16 | -$61.82K derived: sum of 3 quarters · filed 2026-03-16 | -$74.74K 10-K · filed 2026-03-16 |
| 2024-09-30 | -$24.42K 10-Q · filed 2025-11-14 | -$41.48K derived: sum of 2 quarters · filed 2025-11-14 | -$54.39K 10-Q · filed 2025-11-14 | -$82.86K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$17.06K 10-Q · filed 2025-08-14 | -$29.98K 10-Q · filed 2025-08-14 | -$58.44K derived: sum of 3 quarters · filed 2025-08-14 | -$52.53K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$12.91K 10-Q · filed 2025-05-15 | -$41.38K derived: sum of 2 quarters · filed 2025-05-15 | -$35.47K derived: sum of 3 quarters · filed 2025-05-15 | $7.30K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$28.47K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$22.55K derived: sum of 2 quarters · filed 2025-03-31 | $20.21K derived: sum of 3 quarters · filed 2025-03-31 | $57.21K 10-K · filed 2025-03-31 |
| 2023-09-30 | $5.91K 10-Q · filed 2024-11-14 | $48.68K derived: sum of 2 quarters · filed 2024-11-14 | $85.68K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $42.76K 10-Q · filed 2024-08-14 | $79.76K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $37.00K 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | -$4.14M 10-K · filed 2024-04-01 | |||
| 2022-03-31 | -$1.15M 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |